The company announced that sales grew by 7 per cent in 2006 to reach €1.229bn, a figure the company said was largely attributable to the successful implementation of its realignment.
Adjusted EBITDA, which did not take into account non-recurring factors, grew from €193.1m to reach €243.2m, while adjusted EBITDA, which took into account expenses incurred during the company's restructuring programme and its recent IPO, meant that net losses came in at €89.9m.
Breaking the figures down, the companies scent and care division remains its largest source of income, although sales growth was slightly better in the flavour and nutrition division.
The company reported that sales in the scent and care division came in at €674.4m, an increase of 6.5 per cent, whereas EBITDA improved at an even faster rate, rising 29.2 per cent to reach €112.9m.
The company said that the faster market growth was achieved through an emphasis on active cosmetic ingredients, UV filters, special aroma chemicals and sensates, together with fine fragrances, which all recorded double-digit growth.
Likewise the company said that its ingredients ended up in many high profile product launches during the course of 2006, including the Red Delicious line from Donna Karen, as well as Jil Sander's Style and Givenchy's Amarige Mariage.
Symrise chairman Gerold Linzbach said that the company had enjoyed the benefits of a comprehensive restructuring, combined with a significant investment in technological product innovations.
"We reached our ambitious targets in every respect and grew considerably faster than the market," he said. "This dynamic development has continued in the initial weeks of the current financial year, too. We are therefore confident about the rest of the year."
He also stressed the fact that the it had been able to build on its existing core suppliers, due to its strategy in the research and marketing fields, underlined by the development of products that have 'additional benefit'.
Looking ahead the company said it believes it is in a good position to achieve average sales growth of 5 per cent per annum in 2007 and 2008, which adjusted EBITDA is likely to exceed 20 per cent during the period as the benefits of restructuring kick in.
